Author
Listed:
- Huixian Wu
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Daniel Wacker
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Mauro Mileni
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Vsevolod Katritch
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Gye Won Han
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Eyal Vardy
(National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, 4072 Genetic Medicine Building, Chapel Hill, North Carolina 27599, USA)
- Wei Liu
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Aaron A. Thompson
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Xi-Ping Huang
(National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, 4072 Genetic Medicine Building, Chapel Hill, North Carolina 27599, USA)
- F. Ivy Carroll
(Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709, USA)
- S. Wayne Mascarella
(Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709, USA)
- Richard B. Westkaemper
(Virginia Commonwealth University, 800 E. Leigh Street, Richmond, Virginia 23298, USA)
- Philip D. Mosier
(Virginia Commonwealth University, 800 E. Leigh Street, Richmond, Virginia 23298, USA)
- Bryan L. Roth
(National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, 4072 Genetic Medicine Building, Chapel Hill, North Carolina 27599, USA)
- Vadim Cherezov
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Raymond C. Stevens
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
Abstract
Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiological processes, including the regulation of pain, respiratory drive, mood, and—in the case of κ-opioid receptor (κ-OR)—dysphoria and psychotomimesis. Here we report the crystal structure of the human κ-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 Å resolution. The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human κ-OR. Modelling of other important κ-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5′-guanidinonaltrindole, and the diterpene agonist salvinorin A analogue RB-64, reveals both common and distinct features for binding these diverse chemotypes. Analysis of site-directed mutagenesis and ligand structure–activity relationships confirms the interactions observed in the crystal structure, thereby providing a molecular explanation for κ-OR subtype selectivity, and essential insights for the design of compounds with new pharmacological properties targeting the human κ-OR.
Suggested Citation
Huixian Wu & Daniel Wacker & Mauro Mileni & Vsevolod Katritch & Gye Won Han & Eyal Vardy & Wei Liu & Aaron A. Thompson & Xi-Ping Huang & F. Ivy Carroll & S. Wayne Mascarella & Richard B. Westkaemper &, 2012.
"Structure of the human κ-opioid receptor in complex with JDTic,"
Nature, Nature, vol. 485(7398), pages 327-332, May.
Handle:
RePEc:nat:nature:v:485:y:2012:i:7398:d:10.1038_nature10939
DOI: 10.1038/nature10939
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:485:y:2012:i:7398:d:10.1038_nature10939. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.